Discovering and developing innovative therapeutics for CNS disorders

Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company. Our shares are listed on the SWX Swiss Exchange (NWRN). Our mission is to discover, develop and commercialise novel drugs to treat diseases of the Central Nervous System (CNS) and pain.

Research & Drug Development

Voltage-gated Ion Channels

Voltage-gated ion channels are integral membrane proteins that enable the passage of selected inorganic ions across cell membranes. They open and close in response to changes in transmembrane voltage, and play a key role in electrical signalling, governing a number of physiological processes. In vertebrates, electrical signals and the resulting intracellular calcium transients, control contraction of muscle, secretion of hormones, sensation of the environment, processing of information in the brain, and output from the brain to peripheral tissues.

The voltage gated ion channels form a protein superfamily of more than 140 members. It is one of the largest groups of signal transduction proteins, and many family members are the molecular targets for toxins and  therapeutic agents.